Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy

• Hoofdauteurs: Kyle Wesselman, PharmD candidate, MA, BS (Auteur), Vincent Cavaliere, PharmD, MM, BCPP (Auteur), Rakesh Goyal, MD (Auteur), Eric Anderson, MD, MBA, FAPA (Auteur)
• Formaat: Boek
• Gepubliceerd in: American Association of Psychiatric Pharmacists, 2024-02-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Hyperammonemia is a well-known adverse effect of valproate that can progress to a potentially fatal condition known as valproate-induced hyperammonemic encephalopathy (VHE). VHE is more common when valproate is used in combination therapy with other antiepileptic medications. A growing number of cas...